Cargando…

Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt

BACKGROUND: COVID-19 is an illness caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory healthcare workers (LHCWs) are at highest risk for COVID-19 infection due to direct exposure to COVID-19 patients and/or infected samples. OBJECTIVES: Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezz Eldin, Azza M., Kamal, Dalia Tarik, Salah Eldin, Samar, Elkhayat, Mariam R., Attia, Alaa M., Abd Elhameed, Zeinab Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106521/
https://www.ncbi.nlm.nih.gov/pubmed/35573077
http://dx.doi.org/10.1155/2022/7833623
_version_ 1784708305106501632
author Ezz Eldin, Azza M.
Kamal, Dalia Tarik
Salah Eldin, Samar
Elkhayat, Mariam R.
Attia, Alaa M.
Abd Elhameed, Zeinab Ahmed
author_facet Ezz Eldin, Azza M.
Kamal, Dalia Tarik
Salah Eldin, Samar
Elkhayat, Mariam R.
Attia, Alaa M.
Abd Elhameed, Zeinab Ahmed
author_sort Ezz Eldin, Azza M.
collection PubMed
description BACKGROUND: COVID-19 is an illness caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory healthcare workers (LHCWs) are at highest risk for COVID-19 infection due to direct exposure to COVID-19 patients and/or infected samples. OBJECTIVES: Our primary objective in this study was to evaluate SARS-CoV-2 Ab testing as a screening tool for detecting COVID-19 infection among asymptomatic LHCWs. Our secondary aims were to establish the relationship between exposure to COVID-19 infection and subsequent asymptomatic disease and working in different areas of the laboratory. METHOD: The detection of SARS-CoV-2 antibodies was done by different methods (rapid testing, electrochemiluminescence, and chemiluminescent microparticle immunoassay). The study included 199 asymptomatic LHCWs at Assiut University Hospital, Egypt, from different laboratory areas including molecular biology, microbiology, parasitology, and outpatient clinic laboratories in addition to LHCWs involved in automation, phlebotomy, rotating physicians, and those working in the sample receiving area. RESULTS: The incidence of SARS-CoV-2 antibodies by rapid testing and immunoassay among asymptomatic LHCWs was 29.6% and 24.4%. Laboratory phlebotomists (55.6%) were most likely to be exposed to positive patients and samples, followed by those working in the sample receiving area (32%), LHCWs in the automation area (29.6%), rotating doctors (28.6%), and LHCWs in the diagnostic molecular biology laboratory (15.4%). The sensitivities of the rapid test and SARS-CoV-2 total antibody were 94.1% and 92%, whereas the specificities were 92.6% and 91%. CONCLUSION: Rapid serological testing is an effective screening method for the detection of SARS-CoV-2 infection among asymptomatic LHCWs and the identification of the groups of workers who have a significantly higher seroprevalence than the rest of the laboratory population.
format Online
Article
Text
id pubmed-9106521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91065212022-05-14 Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt Ezz Eldin, Azza M. Kamal, Dalia Tarik Salah Eldin, Samar Elkhayat, Mariam R. Attia, Alaa M. Abd Elhameed, Zeinab Ahmed J Environ Public Health Research Article BACKGROUND: COVID-19 is an illness caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory healthcare workers (LHCWs) are at highest risk for COVID-19 infection due to direct exposure to COVID-19 patients and/or infected samples. OBJECTIVES: Our primary objective in this study was to evaluate SARS-CoV-2 Ab testing as a screening tool for detecting COVID-19 infection among asymptomatic LHCWs. Our secondary aims were to establish the relationship between exposure to COVID-19 infection and subsequent asymptomatic disease and working in different areas of the laboratory. METHOD: The detection of SARS-CoV-2 antibodies was done by different methods (rapid testing, electrochemiluminescence, and chemiluminescent microparticle immunoassay). The study included 199 asymptomatic LHCWs at Assiut University Hospital, Egypt, from different laboratory areas including molecular biology, microbiology, parasitology, and outpatient clinic laboratories in addition to LHCWs involved in automation, phlebotomy, rotating physicians, and those working in the sample receiving area. RESULTS: The incidence of SARS-CoV-2 antibodies by rapid testing and immunoassay among asymptomatic LHCWs was 29.6% and 24.4%. Laboratory phlebotomists (55.6%) were most likely to be exposed to positive patients and samples, followed by those working in the sample receiving area (32%), LHCWs in the automation area (29.6%), rotating doctors (28.6%), and LHCWs in the diagnostic molecular biology laboratory (15.4%). The sensitivities of the rapid test and SARS-CoV-2 total antibody were 94.1% and 92%, whereas the specificities were 92.6% and 91%. CONCLUSION: Rapid serological testing is an effective screening method for the detection of SARS-CoV-2 infection among asymptomatic LHCWs and the identification of the groups of workers who have a significantly higher seroprevalence than the rest of the laboratory population. Hindawi 2022-05-06 /pmc/articles/PMC9106521/ /pubmed/35573077 http://dx.doi.org/10.1155/2022/7833623 Text en Copyright © 2022 Azza M. Ezz Eldin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ezz Eldin, Azza M.
Kamal, Dalia Tarik
Salah Eldin, Samar
Elkhayat, Mariam R.
Attia, Alaa M.
Abd Elhameed, Zeinab Ahmed
Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
title Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
title_full Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
title_fullStr Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
title_full_unstemmed Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
title_short Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
title_sort prevalence of sars-cov-2 antibodies in laboratory healthcare workers at assiut university hospital, egypt
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106521/
https://www.ncbi.nlm.nih.gov/pubmed/35573077
http://dx.doi.org/10.1155/2022/7833623
work_keys_str_mv AT ezzeldinazzam prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt
AT kamaldaliatarik prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt
AT salaheldinsamar prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt
AT elkhayatmariamr prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt
AT attiaalaam prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt
AT abdelhameedzeinabahmed prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt